Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Jun 11, 2024)
Date Submitted: Sep 1, 2023
Open Peer Review Period: Sep 1, 2023 - Sep 15, 2023
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Seroepidemiology of SARS-CoV-2 antibody and infection rate estimation following a high-intensity epidemic of COVID-19 in Guangdong Province, China: A large population cross-sectional investigation
ABSTRACT
Background:
Background:
Along with the epidemic response policy adjustment in China, a surge in COVID-19 infection occurred between December 2022 and January 2023. However, the exact proportion of individuals infected during this period remains uncertain.
Methods:
Methods:
A population-level seroepidemiology study was conducted from February to April 2023 in Guangdong Province. The questionnaire and venous blood samples were collected from participants and IgG antibodies against SARS-CoV-2 in serum samples were tested. The chi-square test was used to analyze differences in IgG seroprevalence among participants with different characteristics, and multivariate linear regression was performed to examine the factors affecting IgG levels. Based on a pre-survey cutoff for IgG levels, infection rates (%) for the population were estimated by characteristics.
Results:
Results:
Among the total of 10,747 participants, 10,368 (96.47%, 95%CI: 96.12%-96.82%) were seropositive for SARS-CoV-2 IgG, and the median IgG was 82 (IQR:47-108) S/CO. Seroprevalence and IgG level was lower in the young, the elderly, and participants with chronic diseases. Multiple linear regression analysis revealed significant associations between IgG level and age group, gender, self-reported infection, and latest vaccination time. The infection rate of SARS-CoV-2 in the whole population in Guangdong Province was estimated to be 85.53% following the COVID-19 high-intensity epidemic, corresponding to 107.8 million population were infected.
Conclusions:
Conclusions:
The seropositive for SARS-CoV-2 IgG and the estimated natural infection rate of SARS-CoV-2 in this outbreak in Guangdong province was at a relatively high level. The young and the elderly are vulnerable populations that need to be focused on and protected.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.